Shandong Luba Chemical Co.,Ltd
Beijing Multigrass Formulation Co., Ltd.

USDA approves extra-oil producing gene-edited camelina, not regulated as a GMOqrcode

Favorites Print Sep. 7, 2017
A variety of camelina that’s gene-edited to increase oil content can be grown without undergoing the USDA’s regulatory process for biotech crops.

The agency has determined the camelina cultivar doesn’t pose a plant pest risk, which means it’s outside the USDA’s regulatory jurisdiction over genetically modified organisms, or GMOs.

The crop’s developer, Yield10 Bioscience, relied on a technology known as CRISPR to “knock out” a gene from camelina, eliminating a biological plant activity, thereby allowing it to produce more oil, said Kristi Snell, the company’s chief science officer.

Because the gene-edited cultivar isn’t regulated by USDA, the company can move seeds across state lines and conduct field trials without obtaining a permit, Snell said.

“It really helps shorten the timeline and the cost,” she said.

Yield10 doesn’t aim to become a seed producer, so it would likely license the trait to another company for commercialization, Snell said.

Using CRISPR to alter genes doesn’t fall under USDA’s regulatory purview, but the views of trading partners, such as the European Union, are still evolving, said Snell.

“The jury is still out in these foreign countries,” she said.

The reaction of export markets to gene-edited crops will become apparent once they’re grown on a commercial scale, said Mary Boote, executive director of the Global Farmer Network, which advocates for biotechnology and trade.

More from AgroNews

Magazine

  • Chinese issue of Annual Review 2017 2018 Formulation & Adjuvant Technology
  • 2017 Chinese Issue of CRO Manual<br>2017实验室手册 2017 CRO Manual
  • 2017 Chinese issue of Market Insight<br>2017市场纵览 2017 Seed Special

Subscribe to daily email alerts of AgroNews.